A 5101 (see companion bill S 3336) – New Jersey

Status: Inactive / Dead
Year Introduced: 2019
Link: https://www.njleg.state.nj.us/bills/BillView.asp?BillNumber=A5101

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Return to Database Search

© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found